Max Chat
Calendrier des promotions Ampio Pharmaceuticals, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.Paramètres de base
IPO date
2010-03-31
ISIN
US03209T1097
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 0 | 0 |
| P/BV | 0.4629 | 10 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -150.49 | 0 |
| ROE | -256.9 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.0296 | 10 |
| Debt/Ratio | 0.0478 | 10 |
| Debt/Equity | 0.7071 | 9 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 6099.8 | 10 |
| Rentabilité Ebitda, % | -57.7 | 0 |
| Rentabilité EPS, % | -41.84 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 0.1161 $ | 0 $ | 0 $ | -32.6 % | 0 % | 0 % |
| common.calendar.number_days.7d | 0.0027 $ | 0 $ | 0 $ | 2798.15 % | 0 % | 0 % |
| common.calendar.number_days.30d | 0.003 $ | 0.0027 $ | 0.1305 $ | 2508.33 % | 0 % | 0 % |
| common.calendar.number_days.90d | 0.0021 $ | 0.0006 $ | 0.1305 $ | 3626.19 % | 0 % | 0 % |
| common.calendar.number_days.180d | 0.01 $ | 0.0005 $ | 0.1305 $ | 682.5 % | 0 % | 0 % |
| common.calendar.number_days.1y | 0.0022 $ | 0.0001 $ | 0.45 $ | 3456.82 % | 0 % | 0 % |
| common.calendar.number_days.3y | 0.0943 $ | 0.0001 $ | 104 $ | -17.02 % | 0 % | 0 % |
| common.calendar.number_days.5y | 1.04 $ | 0.0001 $ | 104 $ | -92.48 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0.0001 $ | 0.0001 $ | 104 $ | 116100 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 0.01 $ | 0.0005 $ | 0.1305 $ | 682.5 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Michael A. Martino | CEO, CFO, General Secretary & Director | 550k | 1957 (68 années) |
| Dr. David Bar-Or M.D. | Founder & Chairman of Scientific Advisory Board | 145.6k | 1949 (76 années) |
| April Ramirez | Clinical Trial Manager | N/A |
Informations sur l'entreprise
Adresse: United States, Englewood. CO, 9800 Mount Pyramid Court - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://ampiopharma.com
Site web: https://ampiopharma.com
